Ivan Scandale

1.5k total citations
32 papers, 671 citations indexed

About

Ivan Scandale is a scholar working on Infectious Diseases, Parasitology and Ecology. According to data from OpenAlex, Ivan Scandale has authored 32 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 12 papers in Parasitology and 11 papers in Ecology. Recurrent topics in Ivan Scandale's work include Parasitic Diseases Research and Treatment (12 papers), Parasite Biology and Host Interactions (11 papers) and Parasites and Host Interactions (11 papers). Ivan Scandale is often cited by papers focused on Parasitic Diseases Research and Treatment (12 papers), Parasite Biology and Host Interactions (11 papers) and Parasites and Host Interactions (11 papers). Ivan Scandale collaborates with scholars based in Switzerland, United Kingdom and United States. Ivan Scandale's co-authors include Eric Chatelain, Jennifer Keiser, Mireille Vargas, Gordana Panić, G. Capannelli, A. Bottino, Saverio Russo, Orietta Monticelli, Sabine Specht and Susan A. Charman and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Ivan Scandale

30 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Scandale Switzerland 17 223 196 184 182 127 32 671
Rita Melo Portugal 16 146 0.7× 212 1.1× 46 0.3× 104 0.6× 17 0.1× 47 854
Lucimar F. Kneipp Brazil 17 323 1.4× 66 0.3× 93 0.5× 400 2.2× 12 0.1× 31 734
Prasanta Saini India 13 138 0.6× 99 0.5× 113 0.6× 36 0.2× 63 0.5× 36 473
Mário Lettieri Teixeira Brazil 15 100 0.4× 50 0.3× 103 0.6× 267 1.5× 24 0.2× 50 764
Xiao Shuhua China 16 139 0.6× 880 4.5× 228 1.2× 28 0.2× 551 4.3× 30 1.2k
Khaled M. Al-Qaoud Jordan 19 529 2.4× 400 2.0× 52 0.3× 31 0.2× 279 2.2× 48 1.1k
Helen Rodrigues Martins Brazil 17 44 0.2× 96 0.5× 291 1.6× 306 1.7× 23 0.2× 40 601
Marı́a Celina Elissondo Argentina 22 143 0.6× 799 4.1× 35 0.2× 27 0.1× 333 2.6× 69 1.4k
Wayne L. Smith United States 18 83 0.4× 29 0.1× 25 0.1× 70 0.4× 17 0.1× 40 835

Countries citing papers authored by Ivan Scandale

Since Specialization
Citations

This map shows the geographic impact of Ivan Scandale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Scandale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Scandale more than expected).

Fields of papers citing papers by Ivan Scandale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Scandale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Scandale. The network helps show where Ivan Scandale may publish in the future.

Co-authorship network of co-authors of Ivan Scandale

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Scandale. A scholar is included among the top collaborators of Ivan Scandale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Scandale. Ivan Scandale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touret, Franck, Jean‐Sélim Driouich, Maxime Cochin, et al.. (2024). Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns. Heliyon. 10(10). e30862–e30862. 2 indexed citations
2.
Gokool, Suzanne, Simon Townson, Andrew J. Freeman, et al.. (2024). Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against Onchocerca gutturosa in Gambia. Pharmaceutics. 16(2). 210–210.
3.
Scandale, Ivan, et al.. (2024). Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay. Nature Communications. 15(1). 10530–10530. 1 indexed citations
4.
Driouich, Jean‐Sélim, Raphaëlle Klitting, Géraldine Piorkowski, et al.. (2024). Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains. Antiviral Research. 222. 105814–105814. 13 indexed citations
5.
Gabaldón-Figueira, Juan Carlos, Eric Chatelain, Ivan Scandale, et al.. (2023). State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation. PubMed Central. Volume 14. 1–19. 20 indexed citations
6.
Francisco, Amanda Fortes, Gong� Chen, Wen Wang, et al.. (2023). Preclinical data do not support the use of amiodarone or dronedarone as antiparasitic drugs for Chagas disease at the approved human dosing regimen. SHILAP Revista de lepidopterología. 4. 2 indexed citations
7.
Wattanakul, Thanaporn, Palang Chotsiri, Ivan Scandale, Richard M. Hoglund, & Joel Tärning. (2022). A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics. Expert Review of Clinical Pharmacology. 15(8). 945–958. 4 indexed citations
8.
Hoglund, Richard M., et al.. (2022). Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside. PLoS neglected tropical diseases. 16(3). e0010219–e0010219. 5 indexed citations
9.
Krücken, Jürgen, Lindy Holden‐Dye, Jennifer Keiser, et al.. (2021). Development of emodepside as a possible adulticidal treatment for human onchocerciasis—The fruit of a successful industrial–academic collaboration. PLoS Pathogens. 17(7). e1009682–e1009682. 28 indexed citations
10.
Scandale, Ivan, et al.. (2021). Onchocerciasis drug development: from preclinical models to humans. Parasitology Research. 120(12). 3939–3964. 21 indexed citations
11.
Palmeirim, Marta S., et al.. (2021). Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review. Drugs. 81(8). 907–921. 11 indexed citations
12.
Hübner, Marc P., Coralie Martin, Sabine Specht, et al.. (2020). Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro. PLoS neglected tropical diseases. 14(7). e0008427–e0008427. 26 indexed citations
13.
Hoglund, Richard M., et al.. (2019). DRUG DEVELOPMENT FOR THE TREATMENT AND CONTROL OF ONCHOCERCIASIS: A POPULATION PHARMACOKINETIC ANALYSIS OF EMODEPSIDE (BAY 44-4400) IN HEALTHY VOLUNTEERS. American Journal of Tropical Medicine and Hygiene. 101. 391–392. 1 indexed citations
14.
Häberli, Cécile, et al.. (2019). Evaluation of emodepside in laboratory models of human intestinal nematode and schistosome infections. Parasites & Vectors. 12(1). 226–226. 27 indexed citations
15.
Colella, Vito, Carla Maia, André Pereira, et al.. (2018). Evaluation of oxfendazole in the treatment of zoonotic Onchocerca lupi infection in dogs. PLoS neglected tropical diseases. 12(1). e0006218–e0006218. 13 indexed citations
16.
Keiser, Jennifer, Gordana Panić, Roberto Adelfio, et al.. (2016). Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections. Parasites & Vectors. 9(1). 376–376. 28 indexed citations
17.
Tweats, David, George E. Johnson, Ivan Scandale, James Whitwell, & Dean B. Evans. (2015). Genotoxicity of flubendazole and its metabolitesin vitroand the impact of a new formulation onin vivoaneugenicity. Mutagenesis. 31(3). 309–321. 26 indexed citations
18.
Panić, Gordana, Mireille Vargas, Ivan Scandale, & Jennifer Keiser. (2015). Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni. PLoS neglected tropical diseases. 9(7). e0003962–e0003962. 60 indexed citations
19.
Keenan, Martine, Paul W. Alexander, Wayne M. Best, et al.. (2013). Design, structure–activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi. Bioorganic & Medicinal Chemistry. 21(7). 1756–1763. 27 indexed citations
20.
Longo, Monica, Paolo Colombo, Michael O. Harhay, et al.. (2012). Effects of the benzimidazole anthelmintic drug flubendazole on rat embryos in vitro. Reproductive Toxicology. 36. 78–87. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rita Melo Breakdown of academic impact, for papers by Lucimar F. Kneipp Breakdown of academic impact, for papers by Prasanta Saini Breakdown of academic impact, for papers by Mário Lettieri Teixeira Breakdown of academic impact, for papers by Xiao Shuhua Breakdown of academic impact, for papers by Khaled M. Al-Qaoud Breakdown of academic impact, for papers by Helen Rodrigues Martins Breakdown of academic impact, for papers by Marı́a Celina Elissondo Breakdown of academic impact, for papers by Wayne L. Smith
Rankless by CCL
2026